Therapeutic monitoring of beta-lactams in critically ill patients with sepsis: Clinical trial protocol. | ClinicLens
Sepsis is a leading cause of morbidity and mortality among hospitalized patients and is associated with intensive use of β-lactam antibiotics. These drugs show time-dependent pharmacodynamics and high pharmacokinetic variability in this population, making it difficult to achieve
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.